| Status | Acronym | ISRCTN | EudraCT | NCT (clinicaltrials.gov) | DRKS |
|---|---|---|---|---|---|
| Active |
Remdesivir compassionate use program
Purpose / Objectives
Primary Outcome
Compassionate use program
Diagnosis
- COVID-19 infection
- Infectiology
Patients with proven SARS-CoV-2 infection
Target population
Inclusion criteria
Informed consent for compassionate use and healing attempt, if possible
Documents (password protected)
Go to download area (no documents yet)
Responsibilities in overall study
Sponsor
Gilead Sciences, Inc.
(National) Coordinating Investigator
Priv.-Doz. Dr. med. Philipp Köhler